Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Clinical Trial Diversity Plans: Will US FDA Offer A Gentle Enforcement Hand?

Oct 06 2023

• By Derrick Gingery

diversity — Draft guidance on diversity action plans is due by the end of 2023. • Source: Shutterstock

Related Content

US FDA Calls For Clinical Trial Diversity Plan ‘As Soon As Practicable’ In Product Development

Apr 18 2022

Clinical Trial Diversity Action Plans Required Under US Funding Bill

Dec 21 2022

Pfizer COVID-19 Vaccine Trial Diversity Slips As Enrollment Rises, Unlike Moderna

Sep 18 2020

Sponsors Want Answers On Consequences Of Missing US FDA Trial Diversity Goals

Oct 21 2022

Related Companies

Moderna, Inc.

Additional Topics

United States Clinical Trials Diversity & Inclusion Regulation BioPharmaceutical

More from Clinical Trials

More from R&D

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window